Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SML Mahindra Limited M&A Activity 2025

Apr 26, 2025

60926_rns_2025-04-26_4fcdbe4a-4a77-4bd3-a4b6-0e3e237fe718.pdf

M&A Activity

Open in viewer

Opens in your device viewer

SML/SEC/2025-26/006 Dated: 26[th ] April, 2025

==> picture [65 x 36] intentionally omitted <==

Dy. General Manager,
Corporate Relationship Department
BSE Limited
P.J Towers,
Dalal Street Fort,
Mumbai-400 001
The Secretary,
National Stock Exchange of India Ltd.
Exchange Plaza, 5th Floor,
Plot no. C/1, G Block
Bandra- Kurla Complex
Bandra (E),Mumbai – 400 051
Scrip Code: 505192 Scrip Code: SMLISUZU

Dear Sir(s)

Subject: Intimation under Regulation 30 read along with Schedule III of the Securities and Exchange Board of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation, 2015, as amended from time to time (“SEBI LODR Regulations”).

This is to inform you that the Board of Directors of the Company at their Meeting held today i.e. 26[th ] April, 2025 (Saturday) at Gurugram has taken on record the following and authorized Managing Director & Chief Executive Officer of the Company to execute the same on behalf of the Company:

  • (i) a share purchase agreement between Sumitomo Corporation, Japan (“ Seller 1 ”), Mahindra & Mahindra Limited (“ Purchaser ”) and the Company (“ SPA 1 ”), recording the terms and conditions for transfer of shares of the Company from Seller 1 (Promoter shareholder) to the Purchaser (“ Proposed Transaction 1 ”). Under SPA 1, the Purchaser has agreed to acquire 6,362,306 equity shares representing 43.96% of the equity share capital of the Company from Seller 1, subject to satisfaction of customary conditions precedent (including, but not limited to, receipt of approval from Competition Commission of India (“ CCI ”));

and

  • (ii) a share purchase agreement between Isuzu Motors Limited, Japan (“ Seller 2 ”), the Purchaser and the Company (“ SPA 2 ”), recording the terms and conditions for transfer of shares of the Company from Seller 2 (public shareholder) to the Purchaser, (“ Proposed Transaction 2 ”). Under SPA 2, the Purchaser has agreed to acquire 2,170,747 equity shares representing 15% of the equity share capital of the Company from Seller 2, subject to satisfaction of customary conditions precedent (including, but not limited to, receipt of approval from CCI),

(collectively, referred to as the “ Proposed Transactions ”).

SPA 1 and SPA 2 have been executed on 26[th] April, 2025. However, the signing of SPA 1 and SPA 2 by the Company is only confined and limited to its obligations as mentioned in the relevant clauses of SPAs. Further, the Company is not a party to the terms & conditions agreed between Purchaser and Seller 1, and Purchaser and Seller 2 including commercials.

1

==> picture [65 x 36] intentionally omitted <==

As a result of the Proposed Transactions, the Purchaser will be required to make an open offer to the eligible public shareholders of the Company in accordance with the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, as amended from time to time.

The details required to be disclosed under Regulation 30 read with Paragraph 5 and Paragraph 5A of Part A of Schedule III of the SEBI LODR Regulations read along with SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024 (as amended) (“ SEBI Master Circular ”) are attached as Annexure I A and Annexure I B.

The Board meeting commenced at 06:30 P.M. and concluded at 07:13 P.M.

You are requested to take the same on your records.

Thanking you,

Yours faithfully, For SML ISUZU LIMITED

Digitally signed by Parvesh Madan DN: c=IN, o=Personal, title=0319, pseudonym=CuD89maqW8MkkGFoy0DnVyw7IhcRrr Parvesh Ud, 2.5.4.20=0e1a77d54a096206e1348eb1252e92e878fa cec34c819ffbdaf66cf4ac5b8323, postalCode=160047, st=Chandigarh, serialNumber=321aa9bc0f98ab0fac7ef996a6599ddb 07768433b09197dd51fd989c5a852da3, cn=Parvesh Madan Madan Date: 2025.04.26 20:58:34 +05'30'

(PARVESH MADAN)

Company Secretary & Compliance Officer ACS-31266 [email protected]

2

==> picture [65 x 36] intentionally omitted <==

Annexure I A

Requisite details with respect to SPA 1 pursuant to Schedule III of the SEBI LODR Regulations read along with SEBI Master Circular

S. No Particulars Details
1. If the listed entity is a party
to the agreement, details of
the counterparties (including
name and relationship with
the listed entity).
•Share purchase agreement dated 26thApril,
2025
(“SPA
1”)
between
Sumitomo
Corporation, Japan (“Seller 1”), Mahindra &
Mahindra Limited (“Purchaser”) and SML Isuzu
Limited (“Company”) for the sale of 6,362,306
equity
shares
(“SPA
1
Sale
Shares”)
representing 43.96% of the equity share capital
of the Company, by Seller 1 to the Purchaser,
at a price of Rs. 650/- (Indian Rupees Six
Hundred and Fifty only) per equity share,
subject to satisfaction of customary conditions
precedent (including, but not limited to, receipt
of the approval from Competition Commission
of India (“CCI”)). However, the signing of SPA 1
by the Company is only confined and limited to
its obligations as mentioned in the relevant
clauses of SPA 1. Further, the Company is not
a party to the terms & conditions agreed
between Purchaser and Seller 1 including
commercials.
•Seller 1 is the Promoter of the Company.
•The Purchaser is not related to the Company,
as on the date of SPA 1.
2. If listed entity is not a party
to the agreement:
(i)
name of the party
entering into such an
agreement and the
relationship with the
listed entity;
(ii)
details
of
the
counterparties to the
agreement (including
name
and
relationship with the
listed entity);
(iii)
date of entering into
the agreement.
The Company is a party to the agreement.
However, the signing of SPA 1 by the Company is
only confined and limited to its obligations as
mentioned in the relevant clauses of SPA 1.
Further, the Company is not a party to the terms &
conditions
agreed
between
Purchaser
and
Seller 1 including commercials.

3

==> picture [65 x 36] intentionally omitted <==

S. No Particulars Details
3. Purpose of entering into the
agreement.
SPA 1 records the terms and conditions for the sale
of the SPA 1 Sale Shares representing 43.96% of
the equity share capital of the Company by the
Seller
1
to
the
Purchaser
(“Proposed
Transaction 1”). Please also refer to S. No. 5 of this
Annexure I A for further details.
4. Shareholding, if any, in the
entity
with
whom
the
agreement is executed.

Seller 1 currently owns 6,362,306 equity shares
representing 43.96% of the equity share capital
of the Company.

As on date, the Purchaser does not hold any
equity shares in the Company.
5. Significant
terms of the
agreement (in brief).

The sale of all of SPA 1 Sale Shares from the
Seller 1 to the Purchaser under the SPA 1 is for
an aggregate consideration of
Rs. 4,135,498,900/- (Indian Rupees Four Billion
One Hundred and Thirty Five Million Four
Hundred and Ninety Eight Thousand Nine
Hundred only), subject to terms and conditions
set out in the SPA 1.

Pursuant to the execution of the SPA 1, the
Purchaser will be required to make an open
offer in accordance with SEBI (Substantial
Acquisition
of
Shares
and
Takeovers)
Regulations, 2011.

The consummation of the SPA 1 is subject to
satisfaction of customary conditions precedent
(including, but not limited to, receipt of the
approval from CCI).

The SPA 1 contains terms and conditions, such
as, conditions precedent of the Seller 1 and the
Purchaser, representation and warranties by
the Seller 1 and the Purchaser, indemnity by
Seller 1 to the Purchaser, confidentiality
obligations, etc. However, for the Company, the
following provisions should be noted:

4

==> picture [65 x 36] intentionally omitted <==

S. No Particulars Details
oThe Company to comply with its obligations
and to cooperate with the Purchaser with
respect to filings of relevant applications in
relation to the Proposed Transaction 1 and /
or open offer under applicable law.
oThe
Company to
cooperate
with
the
Purchaser with respect to obtaining approval
of the CCI.
oPost the date of closing under SPA 1, the
Company to take all necessary steps to
cause the change of name of the Company.
oPursuant to the consummation of the
Proposed Transactions, the Purchaser will
acquire control of the Company and will be
classified as the “Promoter” of the Company,
in accordance with applicable law.
oPursuant to the consummation of the
Proposed Transaction 1, the Seller 1 will
cease to be in control of the Company and be
reclassified
from
Promoter
of
the
Company to “Public”, in accordance with
applicable law.
oOn the date of closing under the SPA 1, the
Board of the Company will be reconstituted
to
appoint
nominee
directors
of
the
Purchaser on the Board of the Company
including a new Managing Director, subject to
the receipt of shareholders’ approval in
relation to such appointments.
oThe Company has undertaken certain
standstill
obligations
/
interim
period
covenants that, amongst others, require the
Company to operate in an ordinary course of
business until the closing of SPA 1.
6. Extent and the nature of
impact on management or
control of the listed entity.
•Pursuant to the completion of the Proposed
Transactions, the Purchaser will acquire control
of the Company and will be classified as the

5

==> picture [65 x 36] intentionally omitted <==

S. No Particulars Details
Promoter” of the Company, in accordance with
applicable law.

Pursuant to the consummation of the Proposed
Transaction 1, the Seller 1 will cease to be in
control of the Company and will be reclassified
from “Promoter” of Company to “Public”, in
accordance with applicable law.

On the date of closing under the SPA 1, the
Board of the Company shall be re-constituted
such that:
(a) the Seller 1’s nominee directors on the
Board of the Company (i.e., Mr. Ryusuke
Miyake, Mr. Takahiro Jitosho and Mr. Takashi
Sakuma) and the current Managing Director
and Chief Executive Officer of the Company
(i.e., Mr. Yasushi Nishikawa) will resign; and
(b) the Purchaser will appoint nominee directors
on the board of the Company and nominate
the new Managing Director of the Company.
7. Details and quantification of
the restriction or liability
imposed upon the listed
entity.

Please refer to the paragraph above on
Significant terms of the agreement (in brief)”.

The
Company
has
undertaken
certain
standstill obligations / interim period covenants
that require the Company to operate in an
ordinary course of business until the closing of
SPA 1.
8. Whether the said parties are
related
to
promoter
/
promoter group / group
companies in any manner?
If yes, nature of relationship.

Seller 1 is a Promoter of the Company.

Seller 1 is a related party of certain subsidiaries
of the Purchaser. Consequently, the acquisition
by the Purchaser of 63,62,306 equity shares,
constituting 43.96% of the equity share capital
of the Company, from Seller 1 would be a
related party transaction for Purchaser under
Regulation 2(1)(zc) of SEBI LODR Regulations
and as such would be undertaken at an arm’s
length.

6

==> picture [65 x 36] intentionally omitted <==

S. No Particulars Details
9. Whether
the
transaction
would fall within related
party transactions? If yes,
whether the same is done at
“arm’s length”.
No, the Proposed Transaction 1 is not a related
party transaction in relation to the Company.
10. In case of issuance of
shares to the parties, details
of issue price, class of
shares issued.
Not applicable.
11. Any
other
disclosures
related to such agreements,
viz., details of nominee on
the board of directors of the
listed
entity,
potential
conflict of interest arising out
of such agreements, etc.
Please refer to S. No. 5 of this Annexure I A for
further details.
12. In
case
of
rescission,
amendment or alteration,
listed entity shall disclose
additional details to the
stock exchange(s):
(i)
name of parties to the
agreement;
(ii)
nature
of
the
agreement;
(iii)
date of execution of
the agreement;
(iv)
details and reasons
for
amendment
or
alteration and impact
thereof (including
impact
on
management
or
control and on the
restriction or liability
quantified earlier);
Not applicable.

7

==> picture [65 x 36] intentionally omitted <==

S. No Particulars Details
(v)
reasons
for
rescission
and
impact
thereof
(including impact on
management
or
control and on the
restriction or liability
quantified earlier).

8

Annexure I B

==> picture [65 x 36] intentionally omitted <==

Requisite details with respect to SPA 2 pursuant to Schedule III of the SEBI LODR Regulations read along with SEBI Master Circular

Sl. No Particulars Details
1. If the listed entity is a party to
the agreement, details of the
counterparties
(including
name and relationship with
the listed entity).

Share
purchase
agreement
dated
26thApril, 2025 (“SPA 2”) between Isuzu
Motors Limited, Japan (“Seller 2”), the
Purchaser and the Company for the sale of
2,170,747 equity shares (“SPA 2 Sale
Shares”) representing 15% of the equity
share capital of the Company, by Seller 2 to
the Purchaser, at a price of Rs. 650/-
(Indian Rupees Six Hundred and Fifty only)
per equity share, subject to satisfaction of
customary conditions precedent (including,
but not limited to, receipt of approval from
CCI). However, the signing of SPA 2 by the
Company is only confined and limited to its
obligations as mentioned in the relevant
clauses of SPA 2. Further, the Company is
not a party to the terms & conditions agreed
between Purchaser and Seller 2 including
commercials.

Seller 2 is an existing public shareholder of
the Company.

The Purchaser is not a related party to
the Company, as on the date of SPA 2.
2. If listed entity is not a party to
the agreement,
(i) name of
the party
entering into such an
agreement and the
The Company is a party to the agreement.
However, the signing of SPA 2 by the Company
is only confined and limited to its obligations as
mentioned in the relevant clauses of SPA 2.
Further, the Company is not a party to the terms
& conditions agreed between Purchaser and
Seller 2 including commercials.

9

==> picture [65 x 36] intentionally omitted <==

Sl. No Particulars Details
relationshipwith
the
listed entity;
(ii)
details
of
the
counterparties to the
agreement
(including
name and relationship
with the listed entity);
(iii)
date of entering into the
agreement.
3. Purpose of entering into the
agreement
SPA 2 records the terms and conditions for the sale
of the SPA 2 Sale Shares representing 15% of the
equity share capital of the Company (“SPA 2 Sale
Shares”) held by the Seller 2 to the Purchaser
(“Proposed Transaction 2”). Please also refer to
S. No. 5 of this Annexure I B for further details.
4. Shareholding, if any, in the
entity
with
whom
the
agreement is executed

Seller 2 currently owns 2,170,747 equity shares
representing 15% of the equity share capital of
the Company.

As on date, the Purchaser does not hold any
equity shares in the Company.
5. Significant
terms
of
the
agreement (in brief)

The sale of all of SPA 2 Sale Shares from Seller
2 to Purchaser under the SPA 2 is for an
aggregate consideration of Rs. 1,410,985,550/-
(Indian Rupees One Billion Four Hundred and
Ten Million Nine Hundred and Eighty Five
Thousand Five Hundred and Fifty only), subject
to terms and conditions set out in the SPA 2.

Pursuant to the execution of the SPA 1 and the
SPA 2, the Purchaser will be required to make
an open offer in accordance with SEBI
(Substantial
Acquisition
of
Shares
and
Takeovers) Regulations, 2011.

The consummation of SPA 2 is subject to
satisfaction of conditions precedent (including,
but not limited to, receipt of approval from CCI).

10

==> picture [65 x 36] intentionally omitted <==

Sl. No Particulars Details

The SPA 2 contains terms and conditions, such
as, conditions precedent of the Seller 2 and
Purchaser, representation and warranties by
Seller 2 and the Purchaser, indemnity by
Seller 2 to the Purchaser, confidentiality
obligations, etc. However, for the Company,
the following provisions should be noted:
o The Company to comply with its obligations
and to cooperate with the Purchaser with
respect to filings of relevant applications in
relation to the Proposed Transaction 2 and / or
open offer under applicable law.
o The
Company to cooperate
with
the
Purchaser with respect to obtaining approval
of the CCI.
o Post the date of closing under SPA 2, the
Company to take all necessary steps to
cause the change of name of the Company.
o Pursuant to the consummation of the
Proposed Transactions, the Purchaser will
acquire control of the Company and will be
classified as the “Promoter” of the Company,
in accordance with applicable law.
o On the date of closing under the SPA 2, the
Board of the Company will be reconstituted
to
appoint
nominee
directors
of
the
Purchaser on the Board of the Company
including a new Managing Director, subject to
the receipt of shareholders’ approval in
relation to such appointments.
o The Company has undertaken certain
standstill
obligations
/
interim
period
covenants that, amongst others, require the
Company to operate in an ordinary course of
business until the closing of SPA 2.

11

==> picture [65 x 36] intentionally omitted <==

Sl. No Particulars Details
6. Extent and the nature of
impact on management or
control of the listed entity;

Pursuant to the completion of the Proposed
Transactions, the Purchaser will acquire control
of the Company and will be classified as the
Promoter” of the Company, in accordance with
applicable law.

On the date of closing under the SPA 2, the
Board of the Company shall be re-constituted
such that:
(a) the Seller 2’s nominee director on the Board
of
the
Company
(i.e.,
Mr.
Tomoyuki
Yamaguchi) will resign; and
(b) the Purchaser
will appoint nominee
directors on the Board of the Company and the
nominate
the
Managing
Director of the
Company.
7. Details and quantification of
the
restriction
or
liability
imposed upon the listed entity.

Please refer to the paragraph above on
Significant terms of the agreement (in brief)”.

The
Company
has
undertaken
certain
standstill obligations / interim period covenants
that require the Company to operate in an
ordinary course of business until the closing of
SPA 2.
8. Whether, the said parties are
related to promoter / promoter
group / group companies in
any manner? If yes, nature of
relationship.
None of the parties to SPA 2 form part of the
promoter / promoter group / group companies of
the Company.
9. Whether
the
transaction
would fall within related party
transactions? If yes, whether
the same is done at “arm’s
length”.
No, Proposed Transaction 2 is not a related party
transaction in relation to the Company.
10. In case of issuance of shares
to the parties, details of issue
price, class of shares issued
Not applicable.
11. Any other disclosures related
to suchagreements,
viz.,
Please refer to S. No. 5 of this Annexure I B for
further details.

12

==> picture [65 x 36] intentionally omitted <==

Sl. No Particulars Details
details of nominee on the
board of directors of the listed
entity, potential conflict of
interest arising out of such
agreements, etc.
12. In
case
of
rescission,
amendment
or
alteration,
listed entity shall disclose
additional details to the stock
exchange(s):
(i)
name of parties to the
agreement;
(ii)
nature
of
the
agreement;
(iii)
date of execution of the
agreement;
(iv)
details and reasons for
amendment
or
alteration and impact
thereof
(including
impact
on
management or control
and on the restriction or
liability
quantified
earlier);
(v)
reasons for rescission
and
impact
thereof
(including impact on
management or control
and on the restriction or
liability
quantified
earlier).
Not applicable.

13